Leverage Innovation

At the Molecular Medicine Tri Conference in San Francisco, last week leaders from Pfizer, Johnson and Johnson, Roche and others focused on the need for external partnerships, open innovation and standards.  Chris Waller, Senior Director, Pre Competitive Collaborations, Pfizer, outlined the Pistoia Project focus on pre-competitive partner standards, open innovation amongst its members and individual […]

[Read more →]

Web 3.0 is emerging, as a new generation of target handhelds are widely available. Now, there is wide distribution of a thin client (over 37 million Apple iPods, and iPhones) on handheld devices that are truly programmable and interactive, which are the target of a huge number of diverse personal applications services. Local researchers have jumped […]

[Read more →]

As we have discussed in this blog space, acceleration of drug discovery and research has become an overriding corporate operating objective for pharma/biotech firms.  Drugs have become more specialized and complex, requiring new processes of discovery including, Open Innovation (see post of March 2nd) and collaboration to ‘fast forward’ the research and development process.  After reviewing […]

[Read more →]

Based on comments by a diverse set of Pharma/Biotech industry leaders at last weeks’ Molecular Medicine Tri Conference in San Francisco, there is an emerging interest in developing consortia or one-on-one partnerships to share information about IT frameworks, systems, networks, best practices, vendor selection criteria, open source software, collaborative discovery services and other tools that […]

[Read more →]

In reviewing the remarkable rise of Barack Obama to the Presidency, several aspects of his grass roots movement and consensus building efforts standout that we can learn from.  Here are a few attributes of success in driving complex innovation projects: 

Common Interests – he focused his program, staff, website, and initiatives quite often on common interests […]

[Read more →]

When economic tides are lifting all businesses keeping an innovative ‘ecosystem’ going usually is not as difficult, because management can keep ‘the good business innovation model’ going – approving budgets the same as last year. But what happens when the tides fall, when economic headwinds are blowing hard against your business?  The first indication that the […]

[Read more →]